Showing 172,621 - 172,640 results of 260,524 for search '(( 0 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 2.42s Refine Results
  1. 172621

    Related to Fig 4. <i>NDUFS7</i> depletion in neurons lowers the failure rate of neurotransmission at very low calcium concentrations. by Bhagaban Mallik (12459375)

    Published 2025
    “…<p>(<b>A</b> and <b>B</b>) Representative traces of EPSPs and mEPSPs in (A) motor neuron-Gal4 control (<i>D42-Gal4/+</i>) and (B) motor neuron-Gal4 driven <i>UAS-NDUFS7[RNAi]</i> (<i>UAS-NDUFS7[RNAi]/+</i>; <i>D42-Gal4/+</i>) at 0.15 mM extracellular Ca<sup>2+</sup> concentration. …”
  2. 172622

    Table 1_Evaluation of hypoxia-inducible factor-1α and urine non-transferrin-bound iron concentrations in cats with chronic kidney disease.docx by Chien-Hui Chen (2524213)

    Published 2024
    “…/mL in early-stage CKD cats but decreased to 8.50 pg./mL in late-stage CKD cats. uHIF-1α concentrations gradually decreased with a significant difference between the control group (44.61 pg.…”
  3. 172623

    Circulating Mesenchymal Stem Cells Microparticles in Patients with Cerebrovascular Disease by Suk Jae Kim (135028)

    Published 2012
    “…The levels of CD105<sup>+</sup>/CXCR4<sup>+</sup>/AV<sup>−</sup> microparticles were also increased in patients with severe disability (r = 0.192, p = 0.046 for NIHSS score on admission), but were decreased with time after stroke onset (r = −0.204, p = 0.036). …”
  4. 172624
  5. 172625
  6. 172626
  7. 172627
  8. 172628
  9. 172629

    Correlation between the change in adipocyte diameter and insulin sensitivity after 26-wks VAL or PLB treatment (<i>n</i> = 30) by Gijs H. Goossens (154205)

    Published 2012
    “…<p>The decrease in adipocyte size was significantly associated with alterations in insulin sensitivity after VAL (n = 14, closed circles) and PLB (n = 16, open circles) treatment (<i>r</i> = −0.452, <i>P</i> = 0.012).…”
  10. 172630

    TUNEL positive cells depending on blastomere count. by Anna Leclercq (13928847)

    Published 2022
    “…With increasing blastocyst size (increasing blastomere count), the proportion of TUNEL positive cells decrease (p = 0.002).</p>…”
  11. 172631

    Zonarol suppresses DSS-induced UC in Slc:ICR mic. by Sohsuke Yamada (602944)

    Published 2014
    “…<b>B</b>) The DAI scores were dramatically increased in DSS positive control mice compared with those in the other groups of mice treated with zonarol at 10 mg/kg or 20 mg/kg or 5-ASA 50 mg/kg from day 9 to 15. We observed no apparent difference in the DAI between the mice treated with zonarol and 5-ASA. …”
  12. 172632

    Data_Sheet_1_Evaluating the effect of the plan of national syphilis control in controlling the syphilis epidemic in Jiangsu, China 2010–2020.docx by Lingen Shi (11246098)

    Published 2023
    “…Early syphilis incidence decreased from 21.1 to 8.8 (APC: −7.5, 95%CI: −8.6, −6.5, p < 0.001) per 100,000 people, and congenital syphilis decreased from 63.6 to 4.1 (APC: −14.8, 95%CI: −20.8, −8.4, p < 0.01) per 100,000 newborns from 2010 to 2020. …”
  13. 172633

    Diffusion-weighted magnetic resonance imaging of parotid glands before and after abatacept therapy in patients with Sjögren’s syndrome associated with rheumatoid arthritis: Utility... by Hiroyuki Takahashi (281673)

    Published 2017
    “…Furthermore, SIR was the only parameter that was significantly different between patients with posttreatment increase and decrease in salivary secretion (<i>p</i> = .04). ROC analysis showed the sensitivity and specificity of SIR at baseline of ≥13.0 × 10<sup>−2</sup> for the prediction of the response to abatacept were 75.0% and 83.3%, respectively.…”
  14. 172634

    Kaplan-Meier curves according to variation patterns between the c-IMT tertiles at both time periods. by Domingo Hernández (4919257)

    Published 2015
    “…<p>Solid line indicates the “decrease or stable low-middle” group and dotted line the “increase or stable high” group (log-rank analysis 5.4; <i>P</i> = 0.021).…”
  15. 172635

    Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  16. 172636

    DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  17. 172637

    Image_2_Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.TIF by Yuanliang Yan (475094)

    Published 2019
    “…</p>Methods<p>To elucidate the mechanism maintaining TMZ resistance, we constructed two TMZ-resistant GBM cell lines (T98G-R/U118-R). …”
  18. 172638

    Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  19. 172639

    Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”
  20. 172640

    DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…The primary analysis of the study showed a pathological complete response (pCR) of 32% and no significant decreases in LVEF during chemotherapy. Here, we report important secondary study objectives: 5-year cardiac safety, disease-free survival (DFS), overall survival (OS) and breast cancer specific survival (BCSS).…”